Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers

Philos Public Aff. Fall 1997;26(4):303-50. doi: 10.1111/j.1088-4963.1997.tb00082.x.
No abstract available

MeSH terms

  • Biomedical Technology*
  • Bone Marrow
  • Breast Neoplasms
  • Civil Rights
  • Community Participation*
  • Cost-Benefit Analysis
  • Decision Making*
  • Delivery of Health Care
  • Democracy*
  • Disclosure
  • Economics
  • Ethics*
  • Ethics, Institutional*
  • Growth Disorders
  • Guidelines as Topic
  • Health Care Rationing*
  • Hormones
  • Humans
  • Industry
  • Insurance, Health
  • Insurance, Health, Reimbursement*
  • Jurisprudence
  • Managed Care Programs*
  • National Health Programs
  • Negotiating
  • Patient Selection
  • Private Sector*
  • Public Policy
  • Public Sector
  • Research
  • Resource Allocation*
  • Risk
  • Risk Assessment
  • Social Control, Formal
  • Social Justice*
  • Social Responsibility*
  • Social Welfare
  • Technology Assessment, Biomedical
  • Therapeutic Human Experimentation
  • Therapies, Investigational*
  • Tissue Transplantation
  • United States

Substances

  • Hormones